InsiderTrades.com logo

CMMB Insider Trading

Insider Ownership Percentage: 11.91%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Chemomab Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Chemomab Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Chemomab Therapeutics Share Price & Price History

Current Price: $2.47
Price Change: ▼ Price Decrease of -0.02 (-0.80%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for CMMB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Chemomab Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/3/2023Israel Gp Ltd. OrbimedMajor ShareholderSell84,225$14.32$1,206,102.00560,318View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Chemomab Therapeutics (NASDAQ:CMMB)

46.05% of Chemomab Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CMMB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Chemomab Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/6/2025Rhumbline Advisers9,505$25K0.0%-76.2%0.184%Search for SEC Filing on Google Icon
8/14/2025Orbimed Advisors LLC940,990$1.09M0.0%-46.0%4.990%Search for SEC Filing on Google Icon
5/12/2025Virtu Financial LLC30,803$34K0.0%+113.2%0.215%Search for SEC Filing on Google Icon
4/28/2025Yelin Lapidot Holdings Management Ltd.578,291$0.63M0.1%-22.3%4.027%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd24,929$45K0.0%+63.8%0.174%Search for SEC Filing on Google Icon
2/11/2025Virtu Financial LLC14,445$26K0.0%N/A0.101%Search for SEC Filing on Google Icon
2/5/2025Yelin Lapidot Holdings Management Ltd.744,127$1.35M0.2%-8.1%5.182%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.1,214,575$1.91M0.3%N/A8.458%Search for SEC Filing on Google Icon
2/1/2023Kestra Private Wealth Services LLC31,241$100K0.0%N/A0.271%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP11,277$78K0.0%N/A0.099%Search for SEC Filing on Google Icon
1/28/2022ARK Investment Management LLC267,292$1.84M0.0%+48.1%2.344%Search for SEC Filing on Google Icon
11/17/2021Yahav Achim Ve Achayot Provident Funds Management Co Ltd.3,097$34K0.0%N/A0.027%Search for SEC Filing on Google Icon
11/5/2021Advisor Group Holdings Inc.54,821$0.61M0.0%N/A0.481%Search for SEC Filing on Google Icon
11/3/2021Meitav Dash Investments Ltd.37,567$0.42M0.0%-7.6%0.330%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Chemomab Therapeutics logo
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody had completed Phase 2a clinical trials that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.
Read More on Chemomab Therapeutics

Today's Range

Now: $2.47
Low: $2.42
High: $2.64

50 Day Range

MA: $2.86
Low: $2.41
High: $3.50

52 Week Range

Now: $2.47
Low: $2.36
High: $9.84

Volume

73,974 shs

Average Volume

82,582 shs

Market Capitalization

$15.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.5

Who are the major institutional investors of Chemomab Therapeutics?

Chemomab Therapeutics' top institutional investors include:
  1. Rhumbline Advisers — 0.18%
Learn More about top institutional investors of Chemomab Therapeutics stock.

Which major investors are selling Chemomab Therapeutics stock?

Within the last quarter, CMMB stock was sold by these institutional investors:
  1. Rhumbline Advisers